⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
Pheochromocytoma and Paraganglioma (PCPG) Market to Reach US$670 Million by 2036 at 7.3% CAGR, Driven by Targeted and Radioligand Therapies
globenewswire.com
MRK
NVS
JAZZ
BHC
Global Cell & Gene Therapy Market Size and Forecast Report 2026-2036 | Market to Reach US$126.86 Billion at 17.3% CAGR as CRISPR, CAR-T and Scalable Manufacturing Drive Growth
globenewswire.com
ALLO
ATRA
BEAM
BMRN
BMY
CRSP
GILD
INTC
JNJ
NVS
VRTX
Optogenetic therapy is safe and allows blind people to detect objects
globenewswire.com
NVS
Novartis Rhapsido® (remibrutinib) receives FDA approval as first treatment for symptomatic dermographism (SD), expanding its use beyond chronic spontaneous urticaria (CSU)
globenewswire.com
NVS
Aplastic Anemia - 7MM Market Insights, Epidemiology, and Forecast - 2036 | HSCT and Cell Therapy Advances Create Opportunities Amid Rising Incidence and Generic Pressure
globenewswire.com
TEVA
NVS
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS
accessnewswire.com
NVS
The Mark Foundation Awards $12 Million to Cross-Disciplinary Cancer Research Teams
prnewswire.com
NVS
MRK
BMY
GILD
AZN
PFE
JNJ
BIIB
REGN
MDLZ
OncoBayes poursuit le développement de l'OB-001 pour lutter contre la résistance aux anticorps monoclonaux conjugués et améliorer la pénétration des inhibiteurs de tyrosine kinase dans le cerveau
prnewswire.com
NVS
GILD
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS
globenewswire.com
NVS
Boston, MA Commercial Air Filter Manufacturer Brookaire Now Delivers HVAC Filters to Contractors and Facility Managers Across Massachusetts, Rhode Island, and Connecticut
globenewswire.com
MRNA
BIIB
VRTX
NVS
PFE